Stryker Corporation
SYK
Classifica tra le azioni
#200
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Prezzo delle azioni
$294.17
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$112.84B
Variazione (1 giorno)
0.27%
Variazione (1 anno)
-21.43%
Paese
US
Scambia Stryker Corporation (SYK)
Categoria
Healthcare
Margine operativo per Stryker Corporation (SYK)
Margine operativo al October 2026 TTM: 22.03%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Stryker Corporation, il margine operativo attuale (TTM) è 22.03%. Alla fine del 2024, il margine operativo era 22.40%.
Storico del margine operativo per Stryker Corporation da 2000 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 22.03% | -1.65% |
| 2025 | 22.40% | 0.00% |
| 2024 | 22.40% | 7.28% |
| 2023 | 20.88% | 3.16% |
| 2022 | 20.24% | -8.00% |
| 2021 | 22.00% | 4.27% |
| 2020 | 21.10% | -7.29% |
| 2019 | 22.76% | -0.26% |
| 2018 | 22.82% | 2.61% |
| 2017 | 22.24% | -2.24% |
| 2016 | 22.75% | 0.49% |
| 2015 | 22.64% | -1.74% |
| 2014 | 23.04% | -0.99% |
| 2013 | 23.27% | 5.10% |
| 2012 | 22.14% | -6.70% |
| 2011 | 23.73% | -6.13% |
| 2010 | 25.28% | -1.40% |
| 2009 | 25.64% | 10.85% |
| 2008 | 23.13% | 4.57% |
| 2007 | 22.12% | 6.09% |
| 2006 | 20.85% | 5.14% |
| 2005 | 19.83% | 0.46% |
| 2004 | 19.74% | 5.17% |
| 2003 | 18.77% | 3.25% |
| 2002 | 18.18% | 0.22% |
| 2001 | 18.14% | 15.98% |
| 2000 | 15.64% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 17.03% | -99.23% |
US
|
|
| 17.86% | -99.19% |
IE
|
|
| 21.46% | -99.03% |
US
|
|
| 0.00% | - |
DE
|
|
| 28.09% | -98.72% |
US
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.